Author | Year | Study type | Study population | Follow-up | n | Age (years) | Gender (%) | Surgery/diagnosis | Validation tests |
---|---|---|---|---|---|---|---|---|---|
Gautschi et al. | 2015 | Cohort | Patients ongoing and following lumbar LSS | 6 weeks | 30 | 56.6 | 43.3% women | Lumbar spinal stenosis Lumbar disc herniation Degenerative disc disease | TUG, VAS, RMDI, ODI, SF-12, EQ5D |
Gautschi et al. | 2016 | Cohort | Patients ongoing lumbar LSS | n/a | 253 | 58.4 | 42.0% women | Lumbar spinal stenosis Lumbar disc herniation Degenerative disc disease | TUG, VAS, RMDI, ODI, SF-12, EQ5D |
Gautschi et al. | 2016 | Cohort | Patients ongoing and following lumbar LSS | 6 weeks | 136 | 57.7 | 55.9% women | Microdiscectomy Decompression Fusion surgery | TUG, VAS, RMDI, ODI, SF-12, EQ5D |
Gautschi et al. | 2017 | Cohort | Patients ongoing and following lumbar LSS | 6 weeks | 100 | 46.2 | 43% women | Microdiscectomy Decompression Fusion surgery | TUG, VAS, RMDI, ODI, SF-12, EQ5D |
Jakobsson et al. | 2020 | Clinimetric | Patients ongoing and following lumbar LFS | 6 months | 118 | 46.5 | 54.8% women | Fusion surgery | TUG, 5-MWT, 1-MSCT, 50-FTWT, ODI, VAS, HADS, TSK, PCS |
Stienen et al. | 2019 | Cohort | Patients ongoing LDS with or without fusion | 6 weeks | 64 | 66.8 | 50% women | Decompression with or without fusion | TUG, OFI, VAS, RMDI, ODI, SF-12, EQ5D |
Master et al. | 2020 | Trial | Patients ongoing and following lumbar LSS | 12 months | 248 | 62.2 | 50.8% women | Laminectomy with or without fusion | TUG, 5-STS, ODI, BPI |
Maldaner et al. | 2021 | Cohort | Patients ongoing and following lumbar LSS | 6 weeks | 49 | 55.5 | 41% women | LSS with or without fusion | TUG, VAS, ZCQ, COMI |
Maldaner et al. | 2021 | Cohort | Patients ongoing and following lumbar LSS | 6 weeks | 49 | 55.5 | 41% women | LSS with or without fusion | TUG, 6-MWT, VAS, ZCQ, COMI |
Stienen et al. | 2021 | Cohort | Patients ongoing lumbar LSS | n/a | 70 | 55.9 | 38.6% women | Degenerative disc disease | TUG, VAS, ZCQ, COMI |